Intero Biosystems wants drugmakers to test on mini human intestines, not animals
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by TechCrunch; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories
Why it mattersFlock CEO Garrett Langley said that the surveillance company has not cancelled contracts of any police department or law enforcement agency, despite reports of abuse.
By Chella·3h ago
Why it mattersDatabases have traditionally been designed either for analytical data or for operational data. But database engine CedarDB supports both, and its approach has gained relevance with the rise of agentic AI.
By Chella·1h ago
Why it mattersColossal announced a new AI platform to help accelerate its de-extinction efforts and Peter Diamandis has launched a new fund to back startups who use it.
By Chella·2h ago
Why it mattersI'm just going to come right out and say it. I love the approach Apple has taken with the HomeView.
I'm just going to come right out and say it. I love the approach Apple has taken with the HomeView. I think it's the shared, always-available household interfac…
By Chella·1h ago